Reduced PTEN Expression in Pancreatic Cancer
Author Information
Author(s): Ebert M P A, Fei G, Schandl L, Mawrin C, Dietzmann K, Herrera P, Friess H, Gress T M, Malfertheiner P
Primary Institution: Otto-von-Guericke University
Hypothesis
The overexpression of TGF-β1 in pancreatic cancers may reduce the expression of PTEN, giving cancer cells a growth advantage.
Conclusion
The study found significantly decreased levels of PTEN mRNA in pancreatic cancers, suggesting that TGF-β1 overexpression may contribute to this reduction.
Supporting Evidence
- PTEN mRNA levels were significantly decreased in human pancreatic cancers.
- TGF-β1 transgenic mice showed reduced PTEN expression compared to wildtype mice.
- Incubation of PANC-1 cells with TGF-β1 decreased PTEN mRNA levels after 24 hours.
Takeaway
This study shows that a protein called PTEN, which helps stop cancer, is lower in pancreatic cancer cells, possibly because of another protein called TGF-β1 that is too high in these cells.
Methodology
The study used TGF-β1 transgenic mice, wildtype littermates, and pancreatic tissues from organ donors and patients, assessing PTEN expression through immunohistochemistry and semiquantitative PCR.
Limitations
The study did not investigate the methylation status of the PTEN promoter in cancer samples.
Participant Demographics
Pancreatic cancer tissues were obtained from 10 patients (6 female, 4 male) with a median age of 61.5 years; normal tissues from 10 organ donors (5 female) with a median age of 42 years.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website